magazinelogo

International Journal of Clinical and Experimental Medicine Research

ISSN Print: 2575-7989 Downloads: 171139 Total View: 2209779
Frequency: quarterly ISSN Online: 2575-7970 CODEN: IJCEMH
Email: ijcemr@hillpublisher.com
Article http://dx.doi.org/10.26855/ijcemr.2021.07.026

Discussing Professor Yin Kejing’s Drug Use Law for Mammary Hyperplasia Based on Data Mining Technology

Weiwei Xu, Wenjing Hu, Kejing Yin, Xu Du*

Shaanxi University of Traditional Chinese Medicine, Xianyang, 712046, Shanxi Province, China.

*Corresponding author: Xu Du

Published: July 29,2021

Abstract

Objective: To explore the drug use characteristics and rules of Professor Yin Kejing in the treatment of mammary hyperplasia. Methods: Select the clinical prescription of traditional Chinese medicine for mammary hyperplasia in the past three months, establish a prescription database for traditional Chinese medicine treatment mastosis by using Excel software, use the relevant rule method and cluster analysis in data mining technology, and summarize the characteristics and rules of prescription drugs for traditional Chinese medicine. Results: A total of 80 prescriptions of traditional Chinese medicine were included, involving 170 flavors of traditional Chinese medicine, and the total frequency of use of traditional Chinese medicine was 1,784 times. Among them, the most frequently used traditional Chinese medicine, meridian, four qi and five flavors were Huangqi (80 times), foot yin liver meridian (1,040), temperature (825 times) and bitterness (938 times). The correlation analysis results show that the most supportive combination of traditional Chinese medicine is tulips and plum blossoms. The cluster analysis results show that there are three effective cluster groups. It can be concluded that the drug used to treat mammary hyperplasia is mainly qi-activating blood, supplements qi and blood, treats both specimens, and qi and removes blood stasis. Clinically, the combination of Huangqi-Peonyeoniae-leaked reed-Rebuilding, white mustard-Yanhusuo, and tulips-Zlum flower can be used, and can be dialectically treated according to different clinical classifications.

References

[1] Ma Wei, Jin Quanxiu, Wu Yunfei, Jin Feng. (2016). Expert consensus on diagnosis and treatment of breast hyperplasia [J]. Chinese Journal of Practical Surgery, 2016, 36(07): 759-762.

[2] Wu Yue, Wu Yongqiang, Gao Xiufei, Wang Bei, Zheng Hongbin, Zhang Shuo. (2016). Clinical effect of Chaihu Shugan San and Ganmai Dazao Decoction on the treatment of breast hyperplasia [J]. Journal of Zhejiang University of Traditional Chinese Medicine, 2016, 40(06): 434-438.

[3] Li Yueqing. (2008). Chinese medicine surgery. Beijing: China traditional Chinese Medicine Press, 2008: 113.

[4] Liu Deguo, Li Ziliang, Liu Kai, Chen Xingyuan, Fangying, Fan Hongqiao, Hu Jinhui. (2016). Data mining of the law of drug use in ancient and modern breast cancer (mastoid) [J]. Journal of Hunan University of Traditional Chinese Medicine, 2016, 36(04): 70-73.

[5] Jiang Jun. (2008). Hyperplasia of breast: clinical problems worthy of attention [J]. Chinese Journal of Breast Disease (Electronic Edition), 2008(01): 13-19.

[6] Gao Xuemin Chinese Medicine (m). 2 ed. Beijing: China traditional Chinese Medicine Press, 2010.

[7] Liu Yongxin. (2011). National pharmacopoeia practical manual of traditional Chinese medicine [M]. Beijing: Ancient Chinese Medicine Press, 2011.

[8] Lin Yi, Tang hanjun. (2003). Breast disease of modern Chinese medicine [M]. Beijing: People’s Health Press, 2003.

[9] Jiang Wenting, Zhang Min. (2016). Xiaopi San Jie Decoction and emotional therapy of traditional Chinese medicine in the treatment of breast hyperplasia [J]. Journal of Traditional Chinese Medicine, 2016, 31(12): 1995-1998.

[10] Zheng Shenghong. (2018). Wang Youren’s experience in treating hyperplasia of mammary glands with tongtiaoyin method [J]. Chinese Journal of Traditional Chinese Medicine Information, 2018, 25(06): 115-117.

[11] Yang Yulong. (2018). Clinical study on 45 cases of hyperplasia of mammary glands treated with Xiaojie Decoction and Shuru powder for external use [J]. Asia Pacific Traditional Medicine, 2018, 14(04): 175-176.

[12] Wang Shuxin, Duan Biao, Chen Yujing, Liu Huanling, He Xueping, Chen Hanwei. (2017). Study on the medication regularity of traditional Chinese medicine in the treatment of breast hyperplasia [J]. Chinese Medicine Guide, 2017, 23(23): 50-53.

[13] Wu Yue, Chen Ruiping. (2018). Professor Ruan Guozhi’s experience in treating hyperplasia of mammary glands [J]. Research of Traditional Chinese Medicine, 2018, 31(03): 46-48.

[14] Wen Yinjun. (2019). Research on the academic thought and clinical experience of Ye Tianshi in treating gynecological diseases [D]. Anhui University of traditional Chinese medicine, 2019.

[15] Guo Yue. (2011). Clinical observation on the treatment of hyperplasia of mammary glands with integrated traditional Chinese and Western Medicine [J]. Chinese Community Physician (Medical Specialty), 2011, 13(17): 189-190.

[16] Peng Huaiqing. (2014). Yiqi Xiaohe decoction combined with BAIJIEZI ointment for moxibustion in the treatment of 62 cases of hyperplasia of mammary glands [J]. National Medical Forum, 2014, 29(02): 28-29.

[17] Yu Xianwen, Chen Qiongfang, Wang Gang, Yang Xiufen. (2017). Research progress on chemical constituents and pharmacological effects of Curcuma Kwai [J]. Chinese Journal of Traditional Chinese Medicine, 2017, 35(07): 1891-1893.

[18] Du Yufang, Chen Haifang, Feng Yulin, Song Yonggui, Zhang Wugang, Yang Jie, Yang Shilin. (2013). Research progress on chemical constituents and pharmacological effects of Chimonanthus [J]. Shi Zhen, Guoyi Guoyao, 2013, 24(08): 1981-1983.

[19] Yang Meizhen, Wang Xiaoqin, Liu Yong, Du Yue. (2015). Studies on chemical constituents and pharmacological activities of rhaponticum uniflorum [J]. Chinese Patent Medicine, 2015, 37(03): 611-618.

[20] Du Yiming, Du Xu, Chu Wangchong, Yin Kejing. (2020). Clinical observation on treating blood stasis and phlegm coagulation type of hyperplasia of mammary glands with acupuncture and medicine [J]. Journal of Liaoning University of Traditional Chinese Medicine, 2020, 22(01): 174-177.

How to cite this paper

Discussing Professor Yin Kejing's Drug Use Law for Mammary Hyperplasia Based on Data Mining Technology

How to cite this paper: Weiwei Xu, Wenjing Hu, Kejing Yin, Xu Du. (2021) Discussing Professor Yin Kejing's Drug Use Law for Mammary Hyperplasia Based on Data Mining TechnologyInternational Journal of Clinical and Experimental Medicine Research5(3), 395-402.

DOI: https://dx.doi.org/10.26855/ijcemr.2021.07.026